Longevity University / Lesson 2

Cellular senescence and senolytics

Damaged cells that stop dividing but do not die can inflame nearby tissue. Clearing them helps mice; human evidence is early.

Published Sources checked 4 sourcesEverstack research teamHow we work

A fibroblast, fluorescence: actin in red, microtubules in green
A fibroblast, fluorescence: actin in red, microtubules in green. Image: James J. Faust and David G. Capco, NIGMS, Public domain

Education only, not medical advice. Talk to your clinician before changing medication or if you have a condition.

Cellular senescenceA damaged cell stops dividing (protects against cancer), but if it lingers it secretes inflammatory signals. Senolytics aim to clear it.healthy celldamagesenescentstops dividinginflammatory signalssenolytic clears itmice: yes · humans: early
Cellular senescence. A damaged cell stops dividing (protects against cancer), but if it lingers it secretes inflammatory signals. Senolytics aim to clear it.

What senescence is

Senescence halts the proliferation of damaged cells, which protects against cancer, but senescent cells accumulate with age and secrete inflammatory factors that may disrupt tissues [1]. It is listed among the hallmarks of aging [2].

The mouse evidence

Genetically removing p16-positive senescent cells delayed age-related disorders in progeroid mice [1]. Senolytic drugs (dasatinib plus quercetin) improved physical function and survival in old mice [3].

Where humans stand

The first human pilot, 14 people with lung fibrosis, was open label and showed feasibility only [4]. The leading senolytic company dissolved in 2025 after a mixed phase 2b result (see Frontier). We do not sell senolytics.

Check your understanding

1. Why do cells become senescent in the first place?
  1. To stop damaged cells from dividing, which limits cancer
  2. To store fat
Tap to reveal the answer

Answer: a. Senescence constrains malignant progression [1].

Sources

  1. Baker et al. 2011, Nature. doi.org/10.1038/nature10600
  2. López-Otín et al. 2023, Cell. doi.org/10.1016/j.cell.2022.11.001
  3. Xu et al. 2018, Nat Med. doi.org/10.1038/s41591-018-0092-9
  4. Justice et al. 2019, EBioMedicine. doi.org/10.1016/j.ebiom.2018.12.052

DOIs verified against Crossref on 2026-10-15.

Next: The information theory of aging, sirtuins and NAD+